ASKA Pharmaceutical Holdings Co.,Ltd.

Tokyo Stock Exchange 4886.T

ASKA Pharmaceutical Holdings Co.,Ltd. Operating Cash Flow for the year ending March 31, 2024: USD 9.82 M

ASKA Pharmaceutical Holdings Co.,Ltd. Operating Cash Flow is USD 9.82 M for the year ending March 31, 2024, a -61.08% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

ASKA Pharmaceutical Holdings Co.,Ltd. Operating Cash Flow for the year ending March 31, 2023 was USD 25.22 M, a 8.04% change year over year.
ASKA Pharmaceutical Holdings Co.,Ltd. Operating Cash Flow for the year ending March 31, 2022 was USD 23.35 M, a -60.47% change year over year.
ASKA Pharmaceutical Holdings Co.,Ltd. Operating Cash Flow for the year ending March 31, 2021 was USD 59.07 M, a 1,391.01% change year over year.
ASKA Pharmaceutical Holdings Co.,Ltd. Operating Cash Flow for the year ending March 31, 2020 was USD -4.58 M, a -120.26% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Tokyo Stock Exchange: 4886.T

ASKA Pharmaceutical Holdings Co.,Ltd.

CEO	Mr. Takashi Yamaguchi
IPO Date	April 1, 2021
Location	Japan
Headquarters	5-1, Shibaura 2-Chome
Employees	762
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Medical Instruments Pet Food Pharmaceuticals Plastics

Description

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years